Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single-centre experience.
Oliver C CohenMichele BertelliGavin ManmathanCallum LittleAnne RiddellDebra PollardElsa AradomMolly MussaraChris HarringtonPamela KanagasabapathyRavi De SilvaBruce MartinRita PeraltaKeith GomezThynn YeePratima ChowdaryRoby D RakhitPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
Our experience demonstrates the importance of interdisciplinary communication to identify strategies that decrease the risk of bleeding and thrombosis. The use of extended, increased intensity prophylaxis facilitated antiplatelet therapy. Global assays may help balance the intensity of haemostatic and antithrombotic treatment.
Keyphrases
- antiplatelet therapy
- atrial fibrillation
- percutaneous coronary intervention
- cardiovascular disease
- acute coronary syndrome
- high intensity
- pulmonary embolism
- high throughput
- type diabetes
- stem cells
- coronary artery disease
- cardiovascular events
- metabolic syndrome
- mesenchymal stem cells
- combination therapy
- bone marrow